IFNG and neoplasm: The prognostic and predictive ICI biomarkers has been developed by the use of tissue sample-based methods including measurement of PD-L1 expression to determine the tumor proportion score (TPS) or combined positive score (CPS), tumor mutation burden, microsatellite instability, and interferon (IFN)-γ-related signatures (5–8).